Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-22

Clinical Trial Update: The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Influenza (Acute Upper Respiratory Infection) [Phase 4]

View source ↗

Summary

Phase 4 trial completion evaluating the efficacy and safety of Fuganlin Oral Liquid in children with acute upper respiratory infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fuganlin Oral Liquid

Snippet

Sponsor: Guangzhou Yipinhong Pharmaceutical CO.,LTD | Conditions: Acute Upper Respiratory Infection | Phase 4 | Status: COMPLETED